Using artificial intelligence (AI) virtual navigation to reengage patients who did not attend their colonoscopy appointments may be helpful to potentially motivate them to reschedule their appointments, according to results from a quality improvement study presented at a 2024 ASCO Annual Meeting press conference.

Women who used estrogen-only hormone therapy exhibited increased risk for ovarian cancer incidence and mortality, findings presented during a pre-ASCO press conference showed.

The U.S. Court of Appeals for the District of Columbia on Tuesday ruled in favor of pharmaceutical companies, finding that drugmakers are allowed impose limits on the discounts that they may give under Section 340B of the Public Health Service Act.

Treatment with whole-pelvic radiation therapy (WPRT) may reduce mortality among younger patients with unfavorable-risk prostate cancer, researchers have found.

Older adults from underrepresented populations and those with lower incomes were more likely to have risk factors for severe respiratory syncytial virus disease, a study showed.

Professor Stephen Duffy from the Wolfson Institute of Population Health and colleagues from the University of Liverpool have published the first study in the UK to demonstrate the benefits of lung cancer screening across socioeconomic groups.

After pitched battles over Medicare drug price negotiations, Congress may be pivoting to more bipartisan ground: overhaul of the patent system that allows brand-name drugs to delay competition for years.

Although Aricept (donepezil), a cognition-enhancing drug commonly prescribed for Alzheimer’s disease, did not decrease the effects of chemotherapy-induced cognitive impairment in breast cancer survivors, one researcher said there is still hope, according to an expert.

Lung cancer is the leading causeTrusted Source of cancer-related deaths in the world, but surgical interventions may improve survival rates, particularly when the disease is caught early.

There is no shortage of studies that have shown that colorectal cancer cases are on the rise in younger adults. New data is showing that cases are also rising in children.